Call us today: +1 (304) 470-2225
You can use WPML or Polylang and their language switchers in this area.


Watch 2023 Actinium Pioneering Strategies_Mellalta Meets

Revealed: Actinium KOLs Engagement and Pioneering Strategies for Iomab-B and Actimab-A

As Actinium forges ahead with its transformative therapies, including Iomab-B and Actimab-A, its strategic approach extends beyond clinical trials and regulatory milestones. Actinium’s presentation of six abstracts at the Society for Nuclear Medicine and Molecular […]

Read More